EPIX Pharmaceuticals, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1988-01-01
- Employees
- 91
- Market Cap
- -
- Website
- http://www.epixpharma.com
Clinical Trials
11
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- Interventions
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 236
- Registration Number
- NCT00693004
- Locations
- 🇺🇸
Barrow Neurological Institute, Phoenix, Arizona, United States
🇺🇸PsyPharma Clinical Research, Inc., Phoenix, Arizona, United States
🇺🇸Northwest NeuroSpecialists, PLLC, Tucson, Arizona, United States
An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00677872
- Locations
- 🇺🇸
Massachusetts General Hospital Pulmonary and Critical Care Unit, Boston, Massachusetts, United States
A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 420
- Registration Number
- NCT00672945
- Locations
- 🇺🇸
Barrow Neurological Institute, Phoenix, Arizona, United States
🇺🇸PsyPharma Clinical Research, Inc., Phoenix, Arizona, United States
🇺🇸Northwest NeuroSpecialists, PLLC, Tucson, Arizona, United States
A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder
- Conditions
- Major Depressive Disorder (MDD)
- Interventions
- Drug: Placebo for PRX-00023
- First Posted Date
- 2007-03-16
- Last Posted Date
- 2007-11-14
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 330
- Registration Number
- NCT00448292
- Locations
- 🇺🇸
Vista Medical Research, Inc., Mesa, Arizona, United States
🇺🇸Pharmacology Research Institute, Los Alamitos, California, United States
🇺🇸Synergy Clinical Research Center, National City, California, United States
Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2008-01-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT00384423
- Locations
- 🇺🇸
California Clinical Trials Medical Group, Inc, Paramount, California, United States
🇺🇸Southwest CLinical Research, Rancho Mirage, California, United States
🇺🇸Pacific Research Network, Inc, San Diego, California, United States
- Prev
- 1
- 2
- Next